Acute GVHD models

NL Nicholas D Leigh
KK Kathleen M Kokolus
RO Rachel E O’Neill
WD Wei Du
JE Jason W-L Eng
JQ Jingxin Qiu
GC George L Chen
PM Philip L McCarthy
JF J David Farrar
XC Xuefang Cao
ER Elizabeth A Repasky
request Request a Protocol
ask Ask a question
Favorite

MHC-mismatched transplants were performed using C57BL/6 and WT or β2-AR−/− BALB/c mice as donors and hosts. BALB/c mice received 792 cGy and C57BL/6 mice 965 cGy irradiation from a [137Cs] source 24 hours prior to transplant. Unless otherwise indicated, BALB/c mice received 7×106 total BM IV from C57BL/6 mice. MHC-matched transplants were performed using 129/SvJ as donor and C57BL/6 as hosts. C57BL/6 mice received 965 cGy from a [137Cs] source 24 h prior to transplant. Male C57BL/6 mice were then IV injected with 2×106 female 129/SvJ bone marrow plus 7.5×106 splenocytes and weight loss was tracked. For experiments with T cell depleted bone marrow (TCD-BM), anti-CD90.2 microbeads were used (Miltenyi Biotec). Syngeneic transplants were performed using C57BL/6. C57BL/6 mice received 965 cGy from a [137Cs] source 24 hours prior to transplant, and were given 7×106 total BM IV from C57BL/6 mice. Following transplant, mice were monitored regularly for weight loss and survival. Mice were considered moribund once weight loss reached 20% of their initial weight. For alloHCT involving purified T cells, 3×106 TCD-BM with or without 0.5×106 PanT splenic T cells sorted from C57BL/6 mice were injected into BALB/c hosts. Conversely, C57BL/6 hosts received 4×106 WT BALB/c TCD-BM with or without 3×106 WT or β-AR−/− PanT cells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A